España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Filament Health
FLHLF
OTCQB
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.035000
At close: Nov 18, 3:22 PM EDT
Get Report
Comment
Filament Health (FLHLF) Forecast
News
Earnings
Filament Health (FLHLF) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Filament Health (OTC:FLHLF) Stock
Filament Health Stock (OTC: FLHLF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, April 17, 2024
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Lara Goldstein
Saturday, March 30, 2024
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
Lara Goldstein
Saturday, March 02, 2024
Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More
Lara Goldstein
Thursday, February 15, 2024
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
Lara Goldstein
Tuesday, January 30, 2024
'Rainforests Are Nature's Medicine Cabinets': Biotech Co. Performs Fresh Research On Traditional Plants For Modern Mental Health Challenges
Lara Goldstein
Friday, January 26, 2024
Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
Lara Goldstein
Wednesday, December 27, 2023
Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More
Lara Goldstein
Tuesday, September 26, 2023
Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More
Lara Goldstein
Thursday, September 21, 2023
Peru's Coca Leaf Will Be Used For Research Toward Treating ADHD, Learn The Details
Lara Goldstein
Filament Health and Jaguar Health's Joint Ven...
Benzinga Newsdesk
Thursday, August 24, 2023
Psilocybin Therapy Trials: Gambling Addiction Study, Opioid Pain & Alcohol Addiction Trials
Lara Goldstein
Monday, August 21, 2023
Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports
Lara Goldstein
Tuesday, August 15, 2023
Filament Health Shares Q1 2023 Financials, Material Uncertainties Upon Securing Additional Financing
Lara Goldstein
Monday, July 24, 2023
Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More
Lara Goldstein
Wednesday, July 19, 2023
Filament Health Uplisting To NASDAQ In A $210M SPAC Deal
Lara Goldstein
Tuesday, July 11, 2023
Psyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And More
Lara Goldstein
Friday, July 07, 2023
Filament Supplies Botanical Psilocybin To Canadian Researchers, Inks Global Licensing Deal
Lara Goldstein
Wednesday, May 31, 2023
UCSF Clinical Trial Shows Promising Results For Naturally-Sourced Psilocybin And Psilocin
Lara Goldstein
Tuesday, May 23, 2023
Psyched: New Psilocybin Forms, LSD Anxiety Study, UK's Parliamentary Debate And More
Lara Goldstein
Wednesday, May 17, 2023
African Iboga Root Heads To Canadian Company Developing Natural Drugs To Help Treat Addictions
Lara Goldstein
Monday, May 15, 2023
Psyched: $20M Research Fund, LSD Microdosing For Cancer, MEAI Enters Clinical Stage, Reform Update & More
Lara Goldstein
Filament Health's Q1 2023 Financial Results, Material Uncertainty On The Horizon
Lara Goldstein
Monday, April 17, 2023
Psyched: Clinical-Grade MDMA, LSD For Depression, Partnerships For Delivering Psychedelic Therapies & More
Lara Goldstein
Tuesday, April 11, 2023
Revolutionizing Psychedelics: 2 Industry Leaders Collaborate To Offer Clinical-Grade MDMA Capsules
Lara Goldstein
Monday, April 03, 2023
Filament Health: 2022 Financials And Operational Highlights From Creator Of The Ayahuasca Pill
Lara Goldstein
Tuesday, March 21, 2023
Psychedelic Research Expands In Australia With Palliative Care Partnership & New MDMA Analog Portfolio
Lara Goldstein
Monday, March 20, 2023
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
Lara Goldstein
Wednesday, March 15, 2023
Psychedelic Trials Update: Treating Meth Addiction, Fibromyalgia & General Anxiety Disorder
Lara Goldstein
Tuesday, February 28, 2023
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
Lara Goldstein
Tuesday, February 21, 2023
[Video] Revolutionizing Mental Health: Filament Health CEO Discusses The Future Of Psychedelic Medicine
Benzinga Cannabis
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
Lara Goldstein
Tuesday, February 14, 2023
Supply Partnerships: Filament's Psilocybin Trial In Canada, PharmAla's MDMA Program In Australia
Lara Goldstein
Thursday, January 26, 2023
EXCLUSIVE: Defining 'Natural' Psychedelics, State Regulations & Ayahuasca's Benefits
Lara Goldstein
Wednesday, January 25, 2023
Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More
Lara Goldstein
Friday, January 20, 2023
Psychiatry And Business Collaborate: European Psychedelics Trial Tackles Alcohol Addiction
Lara Goldstein
Tuesday, January 10, 2023
6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements
Lara Goldstein
Tuesday, December 20, 2022
Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK's Research Support And More
Lara Goldstein
Friday, December 16, 2022
EXCLUSIVE: The Psychedelics Debate Is 'Raging' As Filament Debuts Ayahuasca Pill
Lara Goldstein
Thursday, December 15, 2022
Psychedelics Company Filament Signs Licensing Deal With Psyence In US, UK And EU
Lara Goldstein
EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans
Lara Goldstein
Tuesday, December 06, 2022
Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
Lara Goldstein
Thursday, December 01, 2022
Natural Psychedelics Extraction & Standardization Obtains Two New US Patents
Lara Goldstein
Tuesday, November 15, 2022
Psyched: Colorado Legalizes Psychedelics, NYC Treats Alcoholism With Ketamine, $30M Series A For Startup
Lara Goldstein
Friday, November 11, 2022
Filament Health Shares Q3 2022 Results, On Road To Becoming Industry's Natural Psilocybin Supplier
Lara Goldstein
Monday, November 07, 2022
Psyched: Brock Pierce Joins Psychedelic VC, Colorado's Psychedelics Legalization, Zappy Zapolin's Open Letter & More
Lara Goldstein
Friday, November 04, 2022
EXCLUSIVE: Crypto Billionaire Brock Pierce Joins Psychedelic Venture Fund, Says 'Potential Reward Is Immeasurable'
Javier Hasse
Thursday, July 28, 2022
Canada-Based Project Solace Aims To Provide Access And Data On Medical Psilocybin
Lara Goldstein
Friday, July 08, 2022
Filament Begins First Ever FDA-Approved Clinical Trial On Naturally-Derived Psychedelic Drugs
Lara Goldstein
Thursday, June 16, 2022
Canadian Special Access Program Further Authorizes Novel Psychedelic Drugs For Emergency Treatments
Lara Goldstein
Wednesday, June 15, 2022
Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill
Natan Ponieman
Show More
